Smad4 is Associated With Differentiation of Pancreatic Ductal Adenocarcinomas

被引：0
|
作者：
Izumi, S. [1 ]
Ichihara, S. [1 ]
Kubo, T. [1 ]
Ohtani, H. [1 ]
Yano, M. [1 ]
Tanaka, N. [1 ]
Ohashi, R. [1 ]
Onoda, Y. [1 ]
Suzuka, I. [1 ]
机构：
[1] Kagawa Prefectural Cent Hosp, Dept Surg Gastroenterol, Takamatsu, Kagawa, Japan
来源：
PANCREAS | 2014年 / 43卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1369 / 1369
页数：1
相关论文
共 50 条
  • [1] Well Differentiation and Intact Smad4 Expression Are Specific Features of Groove Pancreatic Ductal Adenocarcinomas
    Izumi, Sadanobu
    Nakamura, Satoko
    Mano, Shohei
    Akaki, Shiro
    PANCREAS, 2015, 44 (03) : 394 - 400
  • [2] Poorly Differentiated Histologic Grade is Associated with Worse Overall Survival in SMAD4 Negative Pancreatic Ductal Adenocarcinomas
    Park, E. J.
    Jiang, J. P.
    Dann, A.
    Kim, S. S.
    Damoto, L.
    King, J.
    Hines, O. J.
    Reber, H. A.
    Donahue, T. R.
    Girgis, M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S153 - S154
  • [3] The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma
    Tascilar, M
    Skinner, HG
    Rosty, C
    Sohn, T
    Wilentz, RE
    Offerhaus, GJA
    Adsay, V
    Abrams, RA
    Cameron, JL
    Kern, SE
    Yeo, CJ
    Hruban, RH
    Goggins, M
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4115 - 4121
  • [4] New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas
    Yao, Hongjuan
    Luo, Liaoxin
    Li, Rui
    Zhao, Yelin
    Zhang, Li
    Pesic, Milica
    Cai, Lin
    Li, Liang
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (06):
  • [5] Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis
    Wang, Jin-Dao
    Jin, Ketao
    Chen, Xiao-Ying
    Lv, Jie-Qing
    Ji, Ke-Wei
    ONCOTARGET, 2017, 8 (10) : 16704 - 16711
  • [6] SMAD4 Positive Pancreatic Ductal Adenocarcinomas Are Associated with Better Outcomes in Patients Receiving FOLFIRINOX-Based Neoadjuvant Therapy
    Racu, Marie-Lucie
    Bernardi, Dana
    Chaouche, Aniss
    Zindy, Egor
    Navez, Julie
    Loi, Patrizia
    Maris, Calliope
    Closset, Jean
    Van Laethem, Jean-Luc
    Decaestecker, Christine
    Salmon, Isabelle
    D'Haene, Nicky
    CANCERS, 2023, 15 (15)
  • [7] SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
    Dardare, Julie
    Witz, Andrea
    Merlin, Jean-Louis
    Gilson, Pauline
    Harle, Alexandre
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [8] DPC4/SMAD4 expression is lost in a subset of ductal adenocarcinomas of the pancreas but not in endocrine pancreatic tumors and chronic pancreatitis
    Perren, A
    Hürlimann, S
    Saremaslani, P
    Schmid, S
    Roth, J
    Heitz, PU
    Komminoth, P
    LABORATORY INVESTIGATION, 2002, 82 (01) : 119A - 119A
  • [9] DPC4/SMAD4 expression is lost in a subset of ductal adenocarcinomas of the pancreas but not in endocrine pancreatic tumors and chronic pancreatitis
    Perren, A
    Hürlimann, S
    Saremaslani, P
    Schmid, S
    Roth, J
    Heitz, PU
    Komminoth, P
    MODERN PATHOLOGY, 2002, 15 (01) : 119A - 119A
  • [10] The Over-Expression of Prion Protein Associated with Loss of SMAD4 in Pancreatic Ductal Adenocarcinoma
    Zhang, L.
    Xin, W.
    MODERN PATHOLOGY, 2009, 22 : 326A - 326A
12345